These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 33896665)

  • 1. Ending risk-group HBV vaccination for MSM after the introduction of universal infant HBV vaccination: A mathematical modelling study.
    Xiridou M; Visser M; Urbanus A; Matser A; van Benthem B; Veldhuijzen I
    Vaccine; 2021 May; 39(21):2867-2875. PubMed ID: 33896665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population-level effectiveness of pre-exposure prophylaxis for HIV prevention among men who have sex with men in Montréal (Canada): a modelling study of surveillance and survey data.
    Doyle CM; Milwid RM; Cox J; Xia Y; Lambert G; Tremblay C; Otis J; Boily MC; Baril JG; Thomas R; Blais AD; Trottier B; Grace D; Moore DM; Mishra S; Maheu-Giroux M
    J Int AIDS Soc; 2023 Dec; 26(12):e26194. PubMed ID: 38054579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B vaccination of men who have sex with men in the Netherlands: should we vaccinate more men, younger men or high-risk men?
    Xiridou M; van Houdt R; Hahné S; Coutinho R; van Steenbergen J; Kretzschmar M
    Sex Transm Infect; 2013 Dec; 89(8):666-71. PubMed ID: 23812794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Introducing pre-exposure prophylaxis to prevent HIV acquisition among men who have sex with men in Sweden: insights from a mathematical pair formation model.
    Hansson D; Strömdahl S; Leung KY; Britton T
    BMJ Open; 2020 Feb; 10(2):e033852. PubMed ID: 32029492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of tenofovir-based HIV pre-exposure prophylaxis against HBV infection in men who have sex with men.
    Mizushima D; Takano M; Aoki T; Ando N; Uemura H; Yanagawa Y; Watanabe K; Gatanaga H; Kikuchi Y; Oka S
    Hepatology; 2023 Jun; 77(6):2084-2092. PubMed ID: 36960800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gonorrhoea and chlamydia diagnosis as an entry point for HIV pre-exposure prophylaxis: a modelling study.
    Kasaie P; Schumacher CM; Jennings JM; Berry SA; Tuddenham SA; Shah MS; Rosenberg ES; Hoover KW; Gift TL; Chesson H; German D; Dowdy DW
    BMJ Open; 2019 Mar; 9(3):e023453. PubMed ID: 30837248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling the potential impact of pre-exposure prophylaxis for HIV among men who have sex with men in Cameroon.
    Lyons CE; Stokes-Cawley OJ; Simkin A; Bowring AL; Mfochive Njindam I; Njoya O; Bissek AZ; Tamoufe U; Georges S; Kakanou FZ; Turpin G; Levitt D; Billong SC; Mishra S; Baral S
    BMC Infect Dis; 2022 Sep; 22(1):751. PubMed ID: 36163000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of sexual trajectories of men who have sex with men on the reduction in HIV transmission by pre-exposure prophylaxis.
    Rozhnova G; Heijne JCM; Basten M; den Daas C; Matser A; Kretzschmar M
    Epidemics; 2019 Sep; 28():100337. PubMed ID: 31126778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mathematical model of biomedical interventions for HIV prevention among men who have sex with men in China.
    Li J; Peng L; Gilmour S; Gu J; Ruan Y; Zou H; Hao C; Hao Y; Lau JT
    BMC Infect Dis; 2018 Nov; 18(1):600. PubMed ID: 30486800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can the combination of TasP and PrEP eliminate HIV among MSM in British Columbia, Canada?
    Lima VD; Zhu J; Card KG; Lachowsky NJ; Chowell-Puente G; Wu Z; Montaner JSG
    Epidemics; 2021 Jun; 35():100461. PubMed ID: 33984688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with self-reported hepatitis B virus vaccination status among men who have sex with men in the Netherlands.
    Den Daas C; Adam PCG; Vermey K; Zuilhof W; de Wit JBF
    Sex Health; 2020 Nov; 17(5):444-452. PubMed ID: 33176905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effect of PrEP on HIV Incidence Among Men Who Have Sex With Men in the Context of Condom Use, Treatment as Prevention, and Seroadaptive Practices.
    LeVasseur MT; Goldstein ND; Tabb LP; Olivieri-Mui BL; Welles SL
    J Acquir Immune Defic Syndr; 2018 Jan; 77(1):31-40. PubMed ID: 28961679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of the COVID-19 pandemic on hepatitis B virus vaccination and transmission among men who have sex with men: A mathematical modelling study.
    Xiridou M; Adam P; Meiberg A; Visser M; Matser A; de Wit J; Op de Coul E
    Vaccine; 2022 Aug; 40(33):4889-4896. PubMed ID: 35810058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protocol for a multicenter, real-world study of HIV pre-exposure prophylaxis among men who have sex with men in China (CROPrEP).
    Wang H; Zhang Y; Mei Z; Jia Y; Leuba SI; Zhang J; Chu Z; Ding H; Jiang Y; Geng W; Shang H; Xu J
    BMC Infect Dis; 2019 Aug; 19(1):721. PubMed ID: 31416439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Achieving the "Ending the HIV Epidemic in the U.S." incidence reduction goals among at-risk populations in the South.
    Hamilton DT; Hoover KW; Smith DK; Delaney KP; Wang LY; Li J; Hoyte T; Jenness SM; Goodreau SM
    BMC Public Health; 2023 Apr; 23(1):716. PubMed ID: 37081482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-retroviral Therapy Based HIV Prevention Among a Sample of Men Who Have Sex with Men in Cape Town, South Africa: Use of Post-exposure Prophylaxis and Knowledge on Pre-exposure Prophylaxis.
    Hugo JM; Stall RD; Rebe K; Egan JE; De Swardt G; Struthers H; McIntyre JA
    AIDS Behav; 2016 Dec; 20(Suppl 3):357-364. PubMed ID: 27631366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Pre-exposure Prophylaxis for the Prevention of Human Immunodeficiency Virus Infection on Sexual Risk Behavior in Men Who Have Sex With Men: A Systematic Review and Meta-analysis.
    Traeger MW; Schroeder SE; Wright EJ; Hellard ME; Cornelisse VJ; Doyle JS; Stoové MA
    Clin Infect Dis; 2018 Aug; 67(5):676-686. PubMed ID: 29509889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acceptability of pre-exposure prophylaxis for HIV prevention: facilitators, barriers and impact on sexual risk behaviors among men who have sex with men in Benin.
    Ahouada C; Diabaté S; Mondor M; Hessou S; Guédou FA; Béhanzin L; Batona G; Gning NN; Zannou DM; Alary M
    BMC Public Health; 2020 Aug; 20(1):1267. PubMed ID: 32819335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness analysis of pre-exposure prophylaxis for HIV-1 prevention in the Netherlands: a mathematical modelling study.
    Nichols BE; Boucher CAB; van der Valk M; Rijnders BJA; van de Vijver DAMC
    Lancet Infect Dis; 2016 Dec; 16(12):1423-1429. PubMed ID: 27665989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Achieving 90-90-90 Human Immunodeficiency Virus (HIV) Targets Will Not Be Enough to Achieve the HIV Incidence Reduction Target in Australia.
    Scott N; Stoové M; Kelly SL; Wilson DP; Hellard ME
    Clin Infect Dis; 2018 Mar; 66(7):1019-1023. PubMed ID: 29099920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.